These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23153552)

  • 1. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
    Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
    Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-migration of colon cancer cells and CAFs induced by TGFβ₁ enhances liver metastasis.
    Gonzalez-Zubeldia I; Dotor J; Redrado M; Bleau AM; Manrique I; de Aberasturi AL; Villalba M; Calvo A
    Cell Tissue Res; 2015 Mar; 359(3):829-39. PubMed ID: 25557989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
    Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
    Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
    Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
    J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
    Zhong Z; Carroll KD; Policarpio D; Osborn C; Gregory M; Bassi R; Jimenez X; Prewett M; Liebisch G; Persaud K; Burtrum D; Wang S; Surguladze D; Ng S; Griffith H; Balderes P; Doody J; Schwartz JD; Youssoufian H; Rowinsky EK; Ludwig DL; Witte L; Zhu Z; Wu Y
    Clin Cancer Res; 2010 Feb; 16(4):1191-205. PubMed ID: 20145179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers.
    Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
    Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of epithelial-mesenchymal transition by transforming growth factor β.
    Moustakas A; Heldin CH
    Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
    Serrano I; McDonald PC; Lock FE; Dedhar S
    Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.
    Recalde S; Zarranz-Ventura J; Fernández-Robredo P; García-Gómez PJ; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7090-7. PubMed ID: 21810978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo luminescent imaging of cyclosporin A-mediated cancer progression in rats.
    Ohsawa I; Murakami T; Uemoto S; Kobayashi E
    Transplantation; 2006 Jun; 81(11):1558-67. PubMed ID: 16770245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of EMT by TGFβ in cancer.
    Heldin CH; Vanlandewijck M; Moustakas A
    FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.
    Zarranz-Ventura J; Fernández-Robredo P; Recalde S; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
    PLoS One; 2013; 8(5):e65434. PubMed ID: 23741494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
    Ge R; Rajeev V; Subramanian G; Reiss KA; Liu D; Higgins L; Joly A; Dugar S; Chakravarty J; Henson M; McEnroe G; Schreiner G; Reiss M
    Biochem Pharmacol; 2004 Jul; 68(1):41-50. PubMed ID: 15183116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transforming growth factor-β release from tumor cells reduces their motility associated with epithelial-mesenchymal transition.
    Ohshio Y; Teramoto K; Hashimoto M; Kitamura S; Hanaoka J; Kontani K
    Oncol Rep; 2013 Aug; 30(2):1000-6. PubMed ID: 23715805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs.
    Chen L; Xiao Z; Meng Y; Zhao Y; Han J; Su G; Chen B; Dai J
    Biomaterials; 2012 Feb; 33(5):1437-44. PubMed ID: 22078807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.